Mazzone
Claudio Mazzone, Crespellano (bo) IT
| Patent application number | Description | Published |
|---|---|---|
| 20140374482 | OPTICAL CODE READER - An apparatus for presentation reading of optical information with removable reader includes an optical information reader and a cradle or stand having a seat for seating the reader facing a predetermined optical information reading zone. The reader has an illuminator and the stand has an illuminator. A processor is configured to control a capture of an image of at least one portion of the reading zone, to analyse the image and, based on the analysis, to drive the switching on of either of the illuminator of the reader and/or the illuminator of the stand. The stand includes an optical component at the illuminator of the reader and/or at an aimer of the reader when seated in the seat, to define an aiming pattern and/or to modify the features of the illuminating beam of the reader. | 12-25-2014 |
Claudio Mazzone, Crespellano IT
| Patent application number | Description | Published |
|---|---|---|
| 20100308116 | DATA COLLECTION APPARATUS AND PORTABLE DATA COLLECTION DEVICE - A data collection apparatus includes a portable data collection device, a supporting base arranged for receiving the portable data collection device and connecting means arranged for removably retaining the portable data collection device in the supporting base, the connecting means including magnetic connecting means. | 12-09-2010 |
Damien Julian Mazzone, New South Wales AU
| Patent application number | Description | Published |
|---|---|---|
| 20110162654 | FLEXIBLE STRUCTURE FOR MASK, AND METHOD AND APPARATUS FOR EVALUATING PERFORMANCE OF A MASK IN USES - A respiratory mask includes a frame and a flexible structure provided to the frame and adapted to engage a patient's face. The flexible structure includes a chamber filled with a first gel and a second gel that is relatively harder than the first gel. A ratio of height of the first gel to the second gel in a lip region is in the range of about 0.25 to about 0.6. | 07-07-2011 |
Damien Julian Mazzone, Bella Vista AU
| Patent application number | Description | Published |
|---|---|---|
| 20150335851 | DISCREET RESPIRATORY THERAPY SYSTEM - A device provides respiratory treatment such as for sleep disordered breathing and other respiratory conditions in a discreet configuration to provide a minimally invasive system. The system may include a flow pressurizer apparatus configured to generate a pressurized flow of air through a small bore delivery conduit toward a patient interface. The system may further include a treatment compensator coupled with the fine bore delivery conduit. The treatment compensator may be configured at the patient interface to reduce pressure for patient inspiration. A processor may control adjustments to the pressure generated by the flow pressurizer apparatus. | 11-26-2015 |
Damien Julian Mazzone, Concord West AU
| Patent application number | Description | Published |
|---|---|---|
| 20100000534 | PATIENT INTERFACE SYSTEMS - A patient interface system for delivering a flow of breathable gas to a patient includes a patient interface structure configured to sealingly engage the patient's nares; a pair of strips configured to be connected to opposite sides of the patient interface structure; and adhesive configured to secure the patient interface structure in sealing engagement with the patient's nares. The adhesive may be provided on the strips, and the strips are configured to be adhered to sides of the patient's nose by the adhesive. Another patient interface system includes a first component including adhesive on a first side and hook or loop fastener material on a second side, wherein the adhesive is configured to adhere the component to the face of the patient; and a patient interface structure configured to sealingly engage the patient's airways. The patient interface structure includes a second component including a corresponding loop or hook fastener material configured to engage the corresponding hook or loop fastener material of the first strip to secure the patient interface structure in sealing engagement with the patient's face. A patient interface system for delivering a flow of breathable gas to a patient includes a patient interface structure including a pair of nasal prongs or pillows configured to sealingly engage the patient's nares; and at least one spring configured to bias the nasal prongs or pillows outwards into engagement with the nares of the patient. | 01-07-2010 |
| 20120132208 | CUSHION ASSEMBLY FOR A RESPIRATORY MASK - A mask cushion or a mask assembly therewith provides a comfortable and effective seal for provision of a gas therapy by a respiratory treatment apparatus. The mask cushion ( | 05-31-2012 |
| 20120234326 | MASK SYSTEM - A mask system includes a frame and a cushion provided to the frame. The frame provides a brace or fulcrum like structure about which the cushion may pivot, bend, and/or flex. | 09-20-2012 |
| 20130032154 | PATIENT INTERFACE SYSTEMS - A patient interface system for delivering a flow of breathable gas to a patient includes a patient interface structure configured to sealingly engage the patient's nares; a pair of strips configured to be connected to opposite sides of the patient interface structure; and adhesive configured to secure the patient interface structure in sealing engagement with the patient's nares. The adhesive may be provided on the strips, and the strips are configured to be adhered to sides of the patient's nose by the adhesive. | 02-07-2013 |
| 20130139824 | FILLED HOLLOW STRUCTURE AND METHOD/TOOL FOR MANUFACTURING SAME - Methods and tools for producing a filled hollow structure, comprising producing an open hollow structure from a first material, providing a closing structure to at least partially close the open hollow structure, filling the hollow structure with a filler medium, and overmoulding the filled hollow structure with a second material as well as hollow structures obtainable by said methods and the use of said tools. | 06-06-2013 |
| 20140020687 | DISCREET RESPIRATORY THERAPY SYSTEM - A device provides respiratory treatment such as for sleep disordered breathing and other respiratory conditions in a discreet configuration to provide a minimally invasive system. The system may include a flow pressurizer apparatus configured to generate a pressurized flow of air through a fine bore delivery conduit toward a patient interface. The system may further include a treatment compensator coupled with the fine bore delivery conduit. The treatment compensator may be configured at the patient interface to reduce pressure for patient inspiration. A processor may control adjustments to the pressure generated by the flow pressurizer apparatus. | 01-23-2014 |
| 20140283831 | VENT ARRANGEMENT FOR RESPIRATORY MASK - A control system ( | 09-25-2014 |
Damien Julian Mazzone, Sydney AU
| Patent application number | Description | Published |
|---|---|---|
| 20150314099 | FLEXIBLE STRUCTURE FOR MASK, AND METHOD AND APPARATUS FOR EVALUATING PERFORMANCE OF A MASK IN USE - Headgear for a respiratory mask assembly includes at least one strap. The at least one strap includes one or more bladders filled with a gel. | 11-05-2015 |
| 20150328425 | PATIENT INTERFACE SYSTEMS - A patient interface system for delivering a flow of breathable gas to a patient includes a patient interface structure configured to sealingly engage the face of the patient and a retaining element configured for application to the patient. The retaining element is configured to support the patient interface structure in sealing engagement with the face of the patient. The retaining element includes an adhesive and/or at least one strap. In addition, the patient interface structure is configured to be released from and re-engaged with the retaining element for re-positioning of the patient interface structure relative to the patient's face in a plurality of positions while the retaining element remains supported by the patient. | 11-19-2015 |
Julian Mazzone, Sydney AU
| Patent application number | Description | Published |
|---|---|---|
| 20140150798 | SWIVEL ELBOW AND CONNECTOR ASSEMBLY FOR PATIENT INTERFACE SYSTEMS - A swivel elbow and connector assembly for a patient interface system includes a ring configured to be sealingly secured in an aperture of the patient interface system. The ring includes a first side in an interior of the patient interface system and a second side at an exterior of the patient interface system when the ring is secured in the aperture. The ring also includes a plurality of vents configured to permit flow of gases from the interior to the exterior of the patient interface system. The swivel elbow and connector assembly includes an elbow swivelably secured in the ring. A patient interface system for delivering a flow of breathable gas to a user includes a patient interface structure configured to sealing engage the face of the user. The patient interface structure includes an aperture. A swivel elbow and connector assembly is sealingly secured in the aperture. | 06-05-2014 |
Maria Mazzone, Acireale (catania) IT
| Patent application number | Description | Published |
|---|---|---|
| 20100291226 | Pharmaceutical Formulations Based on Apolar and Polar Lipids for Ophthalmic Use - The present invention refers to pharmaceutical formulations based on lipids for ophthalmic use comprising a phospholipid component composed of zwitterionic phospholipids of natural origin and an oily component composed of oils of natural origin emulsified in water. In particular, the invention refers to ophthalmic formulations useful, for example, for transporting drugs to the eye and in the treatment of ocular dryness, capable of restoring the lipid layer of the tear film. In particular, in a non-transitory but pathological situation such as the dry eye syndrome, such formulations also succeed in reducing the often-present inflammatory component. | 11-18-2010 |
Maria Grazia Mazzone, Acireale IT
| Patent application number | Description | Published |
|---|---|---|
| 20090221545 | Ophthalmic Pharmaceutical Composition Containing Amphiphilic Polyaspartamide Copolymers - The present invention relates in general to the use of amphiphilic graft-type copolymers of polyaspartamide for the ophthalmic administration of drugs, such as for example steroidal and non-steroidal anti-inflammatory agents, antimicrobial agents such as aminoglycosides, macrolides, cephalosporin, tetracycline, quinolones, penicillin, beta-lactams, anti-glaucoma agents such as prostaglandins, alpha- and beta-blockers, inhibitors of carbonic anhydrase, cannabinoids, antiviral agents, diagnostic agents, anti-angiogenic agents, antioxidants. | 09-03-2009 |
| 20110117189 | OPHTHALMIC COMPOSITIONS FOR TREATING PATHOLOGIES OF THE POSTERIOR SEGMENT OF THE EYE - New compositions for ophthalmic use for the prevention and therapy of pathologies of the posterior segment of the eye. These compositions utilize xanthan gum as an active principle carrier, and can be advantageously administered as liquid-gel eye drops on the surface of the eye and optionally used in combination with other therapies for the treatment of the same pathologies. | 05-19-2011 |
| 20110142923 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEOANGIOGENIC PATHOLOGIES OF THE EYE - The present invention relates to ophthalmic pharmaceutical compositions comprising Sorafenib, its derivatives or active metabolites, for the treatment and prevention of ocular neoangiogenic pathologies. | 06-16-2011 |
Massimiliano Mazzone, Kessel-Lo BE
| Patent application number | Description | Published |
|---|---|---|
| 20150258194 | MODULATING TRANSENDOTHELIAL MIGRATION AND RECRUITMENT OF GRANULOCYTES BY MODULATING C-MET PATHWAY - Disclosed are granulocytes and their role in both cancer and inflammation. More particularly, it was found that c-Met expressed by granulocytes is important in transmigration and recruitment of the granulocytes. It is shown that reducing c-Met-mediated transmigration of granulocytes sustains tumor progression, indicating that c-Met-mediated granulocyte transmigration should actually be maintained because it is beneficial in treatment of cancers, particularly cancers that otherwise show resistance to c-Met inhibition. Reducing c-Met-mediated transmigration on the other hand is particularly useful in conditions characterized by an excessive immune response, such as asthma. | 09-17-2015 |
Massimiliano Mazzone, Leuven BE
| Patent application number | Description | Published |
|---|---|---|
| 20120022135 | PHD2 INHIBITION FOR BLOOD VESSEL NORMALIZATION, AND USES THEREOF - A key function of blood vessels, to supply oxygen, is impaired in tumors because of abnormalities in their endothelial lining. PHD proteins serve as oxygen sensors and may regulate oxygen delivery. Therefore the role of endothelial PHD2 in vessel shaping by implanting tumors in PHD2 | 01-26-2012 |
| 20130078224 | INDUCTION/MONITORING OF ARTERIOGENESIS USING SDF1 AND PDGFB OR INHIBITION OF PHD2 - The disclosure relates to the field of ischemia and how to increase tissue perfusion in ischemic tissue by cellular therapy. Specifically, the beneficial effects of myeloid (bone marrow-derived) cells with a particular arteriogenic gene expression profile are shown, and it is shown that increased arteriogenesis and perfusion is specifically due to the effects of combined PDGFB and SDF-1. The arteriogenic gene profile of the myeloid cells used for therapy can, for instance, be obtained by inhibition of PHD2. | 03-28-2013 |
| 20150017159 | MONOCYTE BIOMARKERS FOR CANCER DETECTION - The disclosure relates to the field of biomarkers to diagnose a disease, more particularly to the field of biomarkers to diagnose cancer, and most particularly to colorectal cancer. Specifically, these biomarkers are expressed in monocytes of a subject, particularly circulating monocytes, as can be isolated from peripheral blood. The markers are particularly useful for early detection of cancer. | 01-15-2015 |
Rinaldo Mazzone, Cambiago (mi) IT
| Patent application number | Description | Published |
|---|---|---|
| 20120128359 | METHOD AND SYSTEM FOR BIDIRECTIONAL OPTICAL COMMUNICATION - A method for bidirectional optical communication comprising the steps of:—at a first optical line terminal, directly modulating a laser source to generate a downstream optical signal which has an optical power spectrum comprising two peaks having a frequency separation and a non zero power difference at generation;—propagating said downstream optical signal at a distance along an optical line comprising at least a first optical fiber propagating said downstream optical signal to a second optical line terminal;—at the second optical line terminal: power splitting said downstream optical signal to generate a first and a second power portion of said downstream optical signal, spatially separated; passive filtering said first power portion of said downstream optical signal so as to increase in absolute value a respective power difference of said two peaks, so as to obtain a filtered optical signal which is thereafter detected; and amplitude modulating the second power portion of the downstream optical signal so as to obtain an upstream optical signal having a second amplitude modulation;—propagating back along said optical line the upstream optical signal to the first optical line terminal;—at said first optical line terminal, detecting said upstream optical signal; wherein the method further comprises the step of passive filtering said downstream optical signal and/or said second power portion of the downstream optical signal and/or said upstream optical signal, so as to lower, in absolute value, a respective non zero power difference of said two peaks. | 05-24-2012 |